IRIS
FORNARO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 982
EU - Europa 430
AS - Asia 176
OC - Oceania 2
SA - Sud America 2
Totale 1.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 972
SE - Svezia 127
SG - Singapore 104
IT - Italia 102
DE - Germania 63
CN - Cina 49
RU - Federazione Russa 35
FI - Finlandia 28
FR - Francia 27
GB - Regno Unito 23
BE - Belgio 13
CA - Canada 10
IN - India 8
CZ - Repubblica Ceca 5
JP - Giappone 4
VN - Vietnam 4
IR - Iran 3
NL - Olanda 3
AU - Australia 2
AR - Argentina 1
EE - Estonia 1
ES - Italia 1
GF - Guiana Francese 1
HK - Hong Kong 1
IE - Irlanda 1
KR - Corea 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
Totale 1.592
Salva come PNG Salva come JPEG
Città #
Chandler 170
Fairfield 114
Nyköping 114
Singapore 80
Ashburn 67
Cambridge 49
Houston 49
Munich 46
Woodbridge 43
Seattle 40
Wilmington 36
Ann Arbor 27
Helsinki 27
Lawrence 26
New York 22
Roxbury 18
Bari 17
Inglewood 17
Beijing 15
Brussels 13
Des Moines 13
Princeton 9
London 8
Los Angeles 8
Paris 8
Toronto 7
Milan 6
Redwood City 6
Modugno 5
Naples 5
Pune 5
Santa Clara 5
Brno 4
Dong Ket 4
Florence 4
Nanjing 4
San Diego 4
San Francisco 4
Shanghai 4
Trani 4
Brooklyn 3
Hebei 3
Leawood 3
Ottawa 3
San Mateo 3
Ardabil 2
Brindisi 2
Cerveteri 2
Dearborn 2
Frankfurt am Main 2
Massa 2
Monmouth Junction 2
Mumbai 2
Prescot 2
Saint-Fons 2
Verdellino 2
Wuhan 2
Augusta 1
Berlin 1
Bitonto 1
Brescia 1
Brugherio 1
Buffalo 1
Campo San Martino 1
Canberra 1
Clifton 1
Dublin 1
Esslingen am Neckar 1
Gatteo 1
Greenwich 1
Grottaglie 1
Haikou 1
Hat Yai 1
Hong Kong 1
Hounslow 1
Jacksonville 1
Kilburn 1
Madrid 1
Melbourne 1
Mola Di Bari 1
Mountain View 1
Nagold 1
Nanchang 1
Norwalk 1
Offanengo 1
Olomouc 1
Remire-Montjoly 1
Rizhao 1
Shenyang 1
Tallinn 1
Tianjin 1
Tokyo 1
Washington 1
Wuxi 1
Zhengzhou 1
Totale 1.184
Salva come PNG Salva come JPEG
Nome #
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 111
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 109
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 96
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 89
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 89
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 76
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 71
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 67
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 65
Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis 59
Sindrome anti-sintetasi: due casi di anti-EJ (anti-glycyl-tRNAsintetasi) 51
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment 51
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients 47
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 47
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 44
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 40
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 38
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 38
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 37
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 36
Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study 32
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 32
Cartilage damage: clinical approach 32
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 30
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 29
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 28
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 22
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 22
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 21
Complete Hydatidiform Mole Mimicking Sacroiliitis 20
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 13
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 13
Predictors of long-term clinical remission in rheumatoid arthritis 12
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 11
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 11
Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors 10
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 10
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases 10
Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult with Seronegative Rheumatoid Arthritis 9
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 8
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registry 8
Letters to the editors 8
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 7
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 6
Paradoxical Pustular Psoriasis in a Patient with Psoriatic Arthritis on Secukinumab Treatment 6
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 6
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry 5
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 4
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 3
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 3
Mobile session fixation attack in micropayment systems 3
Effectiveness of Tapering Rituximab Dose in Idiopathic Inflammatory Myopathies: Real-World Data from a Monocentric Study 3
Integrating large language models in medicine: a study of Claude 2’s performance in MDAAT scoring for idiopathic inflammatory myopathies 2
The impact of multimorbidity on QoL in inflammatory myopathies: COVAD cluster analysis 1
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study 1
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the biologic apulian registry (BIOPURE) 1
Totale 1.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 26 32 35 23 20 12
2020/2021194 5 14 9 6 18 15 22 23 22 19 31 10
2021/2022226 9 2 5 10 9 11 25 14 17 30 32 62
2022/2023455 46 76 30 31 30 69 9 66 61 6 19 12
2023/2024221 17 45 13 19 13 41 9 6 3 7 3 45
2024/2025327 42 13 62 26 25 136 23 0 0 0 0 0
Totale 1.703